Israeli start up develops ‘brain-decoding’ AI in hopes of treating Alzheimer’s disease and PTSD
The firm has trained its AI model, named Descartes, using 250,000 hours of EEG brain data
Assessment
The development of Descartes, trained on 250,000 hours of EEG data, marks a significant effort to apply AI to neurological conditions. The potential applications for Alzheimer's and PTSD are notable, but no details on efficacy or timeline are provided in this report. Further context on the startup's clinical progress is needed.